chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 weeks after the second shot I have pain in my arm from the shot area down to my hand.; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 75-year-old) as a single dose for COVID-19 immunisation. Medical history included drug allergy (sulfur). The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Feb2021 at 14:30 (at the age of 75-year-old) as a single dose for COVID-19 immunisation. On 12Apr2021 at 08:00, five weeks after the second shot, the patient experienced pain in arm from the shot area down to hand. This has been going on for one week. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse event which included treatment with Aspirin (which helped only somewhat). The clinical outcome of the event pain in arm from the shot area down to hand was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Brain fog; Forgetfulness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Mar2021 (at the age of 45-years-old) at 09:15 as a single dose for COVID-19 immunisation. Medical history included known allergies to corn, turkey, pork, strawberries and rye. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 08Mar2021 at 07:30, the patient experienced brain fog, she kept writing a instead of h while teaching. This was her 17th year teaching that subject, no way she would make that mistake over and over again normally. The patient also had forgetfulness, she kept forgetting what she was teaching, as she was teaching it which was not normal for her at all. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog and forgetfulness was resolving at the time of the report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
2nd dose of Moderna administered at 11:00 am on 4/20/2021.  Felt great all day until 10:30 pm.   10:30 pm on 4/20/2021 - full body shivers, fluctuating fever from 100.1 to 101.0, profuse sweating, nausea, and full body joint aches.   Pain at site of injection.  4/21/2021 - missed work due to side effects - full body shivers, fluctuating fever from 100.1 to 101.0, profuse sweating, nausea, full body joint aches, and fatigue.   Pain at site of injection.  Side effects lasted from approximately 10:30 pm on 4/20/2021 and subsided sometime (while sleeping) during the overnight hours between 4/22/2021 and 4/23/0221.  Mild fatigue and pain at injection site remain but improving.
On 7/4/06 he had a sting.  He had local swelling.  He was treated in the emergency room 7/5/06.  He was given Prednisone 60 mg a day for 3 days and BENADRYL.  He also was given a tetanus shot.  I can not tell you for sure which form, but it would have been an adult form.  On 7/12/06 he had some chest pain and a feeling.  The patient was admitted to the hospital with urticaria, etiology not well documented. Did have an episode of bee sting treated for a few days with steroids.  Doctor did not feel this could be a late reaction to that but the patient id have impression urticaria and some laryngeal edema when seen in the emergency room.  The patient came back to the emergency room, was seen, admitted and left due to the fact that he had improved significantly and signed out against medical advice.  On this admission, returned again with hives and edema and stayed for more complete workup and consult to doctor.  The patient improved significantly with steroids, was adjusted to 30 mg and additional follow-up on an outpatient basis to find an etiology of same.  Did have some hives as a child but no specific etiology was found at that time and had not been followed up with an allergist for similar symptoms through is adult life.  The patient discharged in good condition in care of family on steroids.  BENADRYL and TAGAMET.  Follow up in the office.
Periodic vomiting for 3 days after vaccinne, mild case of Rubella (German Measles) 8 days after vaccine that lasted 4 days, vomiting 11 days after vaccine.  Reporting the Rubella onset.
This spontaneous report as received from a physician refers to a female patient of unknown age. The patient was received 3 doses of GARDASIL (route, dose and lot # were unknown) in the past, started "about a year ago" (in 2011). Specific dates of administration for the GARDASIL were unavailable. No other co-suspects were reported. No concomitant medications were reported. Now the patient had a positive pap smear test. At the report time the outcome of event was unknown. It was unknown if the patient sought medical attention. Additional information has been requested.
Extreme fatigue, extreme dizziness, loss of appetite, fever of just over 102, muscle ache
A non-serious, spontaneous report of administered expired FLUMIST was received from a health professional concerning three children. Neither past medical history nor concomitant medications were reported for this patient. The product expired on 28-Nov-2010 or 29-Nov-2010. On 20-Dec-2010, the patient received expired product. There were no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable and the event is considered resolved.
the needle site was bruised; felt exhausted; This is a spontaneous report received from Pfizer sponsor program reported from a non-contactable consumer (patient). A 27-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 03May2021 (at the age of 27-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on unspecified date (at the age of 27-years-old) as DOSE 1, SINGLE for covid-19 immunisation. On 05May2021, the day after get-ting second shot the patient felt exhausted and noted "the needle site was bruised". He considered these symptoms to be "Very mild". The outcome of the events unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
involuntary facial movements; neck twisting; This case was reported by a physician and described the occurrence of movements involuntary in a 6-year-old patient who received Hepatitis B vaccine (batch number U32D9, expiry date 5th February 2022) for prophylaxis.   On 6th July 2021, the patient received Hepatitis B vaccine. On 20th July 2021, 14 days after receiving Hepatitis B vaccine, the patient experienced movements involuntary and stiff neck. On an unknown date, the outcome of the movements involuntary was not recovered/not resolved and the outcome of the stiff neck was unknown.   It was unknown if the reporter considered the movements involuntary and stiff neck to be related to Hepatitis B vaccine.  Additional details were provided as follows: The patient received dose of Hepatitis B vaccine and experienced involuntary facial movements and neck twisting. On 20th July 2021, the reporter saw the patient with the above complaints and told mother to observe.  The patient was still with involuntary movements. No further information reported. The reporter consented to follow-up.
Pt recv vax on 12/2/98; on 12/12/98 pt exp rash on stomach, back,face & neck; tx=as if chicken pox
Symptoms - Shoulder pain, neck pain, cervical herniated disk. Time course - 9/16/2015 to present. Treatments - cortisone, physical therapy, muscle relaxers (orphenadrine citrate).
Family member scheduled patient for an appointment and requested the Pfizer vaccine.   When patient came in for his appointment, the Pfizer vaccine was administered; however,  when he showed his  COVID card to document the vaccine, he had previously received the Moderna vaccine - no known side effects.
02/03/2010 Pt. walked in with Swelling, redness and pain of right upper arm and elbow. Pt sent to Emergency Department to r/o cellulitis.
Pt was found to be immune to rubella. Eight days post vax, pt experienced a rash on both inner thighs, right arm and a few red spots were noted on her abdomen.  Rash was described as small, red, raised and irregularly shaped pruritic welts. Pt was afebrile and otherwise felt well.
Itching is unbearable; Rash spread to the shoulder, upper back, lower back, stomach, front and back of legs; rash starts at the upper neck and continues down the legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching is unbearable) and RASH (Rash spread to the shoulder, upper back, lower back, stomach, front and back of legs; rash starts at the upper neck and continues down the legs) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 036L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included AMLODIPINE, APIXABAN (ELIQUIS), METOPROLOL SUCCINATE (TOPROL XL) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced RASH (Rash spread to the shoulder, upper back, lower back, stomach, front and back of legs; rash starts at the upper neck and continues down the legs). On an unknown date, the patient experienced PRURITUS (Itching is unbearable). The patient was treated with TRIAMCINOLONE at a dose of 0.1 %. At the time of the report, PRURITUS (Itching is unbearable) and RASH (Rash spread to the shoulder, upper back, lower back, stomach, front and back of legs; rash starts at the upper neck and continues down the legs) outcome was unknown.            Concomitant medications included nitrol patch daily.  Patient reported treatment of steroid cream prescribed from dermatologist helps temporarily.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-037085 (Patient Link).
Nausea, vomiting x 2, chills, muscle ache, sever headache, and fever 100.2
chills light; Headache; chills; Headache; chills; low fever; body aches; This spontaneous case was reported by a patient and describes the occurrence of the first episode of HEADACHE (Headache), the first episode of CHILLS (chills), PYREXIA (low fever), MYALGIA (body aches) and the second episode of HEADACHE (Headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A, 022M2DA, 033F21A and 014B22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Patient had never been tested positive or diagnosed with COVID-19.  Concurrent medical conditions included Diabetes since 2008, Hypertension (HBP), Thyroid disorder (Thyroid), Drug allergy (Ceclor) and Sleep disorder (Sleep aid). Concomitant products included FEXOFENADINE for Allergy, PRAVASTATIN for Cholesterol, METFORMIN for Diabetes, VALSARTAN and NIFEDIPINE for Hypertension, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Sleep disorder, LEVOTHYROXINE for Thyroid disorder, MULTIVITAMIN & MINERAL, MAGNESIUM and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced the first episode of HEADACHE (Headache), the first episode of CHILLS (chills), PYREXIA (low fever) and MYALGIA (body aches). On 18-Feb-2021 at 5:00 PM, the patient experienced the second episode of HEADACHE (Headache) and the second episode of CHILLS (chills). On 07-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (chills light). On 22-Jan-2021, PYREXIA (low fever) and MYALGIA (body aches) had resolved. On 19-Feb-2021, last episode of HEADACHE (Headache) and the last episode of CHILLS (chills) had resolved. On 07-Jul-2022, CHILLS (chills light) had resolved.            On 21-Jan-2021, at 03:00 A.M and 03:00 P.M, the patient experienced the first episode of HEADACHE (Headache), the first episode of CHILLS (chills), PYREXIA (low fever) and MYALGIA (body aches).  The events did not cause the patient to seek medical care.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-741758 (Patient Link).
Patient went to the ER 8 hours after receiving her second booster of Moderna with heart palpitations. She received tests and monitoring and was sent home. She's doing much better today.
extreme arm pain, very bad chills, severe body aches, head  and neck pain this occurred a couple of hours after the injection and completely resolved in 48 hours patient received no treatment
Papanicolaou smear positive; she is unsure if she received the third dose of Gardasil; she is unsure if she received the third dose of Gardasil; This spontaneous report was received from a consumer concerning to herself a patient of unknown age. The patient's concurrent conditions, concomitant medications, pertinent medical history, previous drug reactions and allergies were not reported.  On an unknown date, the patient was vaccinated with the first dose and second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) for prophylaxis (strength, dose, route of administration, lot number and expiration date were not reported).  On an unknown date, the patient reported that she tested positive for a pap smear test (smear cervix abnormal). Additionally, the patient was unsure if she received the third dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (inappropriate schedule of product administration and circumstance or information capable of leading to medication error).    The outcome of smear cervix abnormal, inappropriate schedule of product administration and circumstance or information capable of leading to medication error was unknown.    The causality assessment between quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) and the event of smear cervix abnormal was not reported.
I was showering and all of sudden felt something in my left eye looked in the mirror and it was blood shot red. I went to the doctor and they gave me eyedrops. A few days later I started getting a rash all over my body. Then eventually it started going away. Then I had a mild case of gout.
Very dizzy with loud ringing in both ears. Fever, body aches, headache. I expected the fever/body aches but the extreme dizziness makes driving/working not possible.
Painful in my armpit, in my arm.; It's extremely swollen or just painful in my armpit..; I was trying to see my lymph, warm.; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0185, Expiry date: unknown), dose 2 via an unspecified route of administration on 14May2021 as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications was not reported. Historical vaccine of BNT162B2 for COVID-19 immunization as first dose. The patient experienced painful in armpit, in the arm, it's extremely swollen or just painful in armpit and patient was trying to see lymph, warm on an unspecified date. The patient had actually received last vaccine, the second one on Friday, that was 14 and was trying to see and looked at the paper work it said some of the side effects could be swollen lymph nodes and pain that mentioned. So, I was trying to see my lymph, warm. Patient was done with both shots and it was extremely swollen or just painful in armpit. In the arm was trying to see how long this side effect, would last. When probed whether the adverse events are from the second shot, patient stated, yes. Patient stated, on the vaccination card. Yeah, You need my card. That's what I can make it out. It was just for first one then I have for second one. Patient stated, on the vaccination card. Yeah, You need my card. Patient would like to talk to someone else. The outcome of events was unknown.  No follow-up attempts are needed. No further information is expected.
Began with back pain and headache 1st day, 2nd day generalized muscle and joint pain and headache lasting 7 more days, chills and fever. On day 8 bad severe nausea, diarrhea, fever, chills, almost fainted. Took 10 days for all symptoms to resolve.
Patient complained of stiffness/right side; headache, dizziness after receiving first dose of Pfizer; Comprehensive nursing assessment done including vital signs, pain, neurological status.  Patient stated she had no difficulty swallowing.  She was given water.  Vital signs remained stable.
Six days after the shot I had a severe rash/hives all over my body; Six days after the shot I had a severe rash/hives all over my body; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL1284), via an unspecified route of administration on 14Jan2021 03:15 at single dose for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was hospital. Medical history included Colitis, Arthritis, Allergies to Penicillin, Allergies to Mugwort. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included celecoxib (CELEBREX). The patient experienced ''six days after the shot i had a severe rash/hives all over my body'' (non-serious) on 20Jan2021 07:00.  AEs resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. Patient was not pregnant. Therapeutic measures were taken as a result of events (treatment: benedryl, zyrtec, Pepcid). The outcome of events was not recovered.
high fever; chills; myalgia; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, chills and myalgia. On an unknown date, the outcome of the fever, chills and myalgia were recovered/resolved.   It was unknown if the reporter considered the fever, chills and myalgia to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient experienced high fever, chills and myalgia after the 1st dose of Shingrix. The reporter did not consent to follow up. The case is linked with the case-US2020188955, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020188955:same reporter
Patient had baseline headaches less than 1X per month.  This increased after the initial COVID vaccination to be daily.  These headaches have since decreased to becoming a few times per week, and now they are back to being once every week or every other week.    Additionally patient was found to have a DVT of the left lower extremity found 8/4/2021.  This DVT was likely present prior to that date are unknown timeframe.  Patient has family history of DVTs, but person in question (father) had that postoperatively at age 60.  Patient is otherwise active, with walking the majority of the day.  Patient will be driving for 30 minutes or less periodically between destinations and then be lifting and standing for the remainder of the 12-hour shift.  Patient had no other medication changes, or provoking factors for this DVT. Patient was placed on Xarelto after the DVT was discovered.
unable to sleep at night; injection site swelling; injection site soreness; feeling tired; fever; chills; muscle pain; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd April 2019, the patient received the 1st dose of Shingrix (intramuscular). In April 2019, less than a week after receiving Shingrix, the patient experienced injection site swelling, injection site pain, tiredness, fever, chills and muscle pain. On 22nd April 2019, the patient experienced difficulty sleeping. On an unknown date, the outcome of the injection site swelling, injection site pain, tiredness, fever, chills, muscle pain and difficulty sleeping were unknown.   It was unknown if the reporter considered the injection site swelling, injection site pain, tiredness, fever, chills, muscle pain and difficulty sleeping to be related to Shingrix.  Additional details were provided as follows: The patient who received Shingrix before the date of reporting. She was experiencing feeling tired, fever, chills, muscle pain, injection site swelling and soreness, and unable to sleep at night.  Did not consent to follow up.
The baby was found dead in the crib. Autopsy report states death due to myocarditis.
Patient was given the COVID vaccine 0.2 ml before the vaccine was mixed with the diluent
Friend not feeling great after second dose; This is a spontaneous report from a non-contactable consumer reporter for his friend. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that his friend not feeling great after second dose on an unspecified date with outcome of unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021238689 same reporter/drug/event, different patient